Next Article in Journal
KOnezumi-AID: Automation Software for Efficient Multiplex Gene Knockout Using Target-AID
Previous Article in Journal
Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab–Paclitaxel Therapy Outcomes in Advanced Gastric Cancer
Previous Article in Special Issue
Redox Chemistry: Implications for Necrotizing Enterocolitis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 25
Issue 24
10.3390/ijms252413497
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preeclampsia Treatment Aspirin/Clampsilin: Oxidative Stress, sFlt-1/PIGF Soluble Tyrosine Kinase 1, and Placental Growth Factor Monitoring

by
Denitsa Kostadinova-Slavova
1,
Kamelia Petkova-Parlapanska
2,
Irina Koleva
2,
Mariya Angelova
3,
Rafaah Sadi J. Al-Dahwi
1,
Ekaterina Georgieva
4,
Yanka Karamalakova
2 and
Galina Nikolova
2,*
1
Obstetrics and Gynaecology Clinic, UMHAT “Prof. St. Kirkovich”, 6000 Stara Zagora, Bulgaria
2
Department of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria
3
Department of Obstetrics and Gynecology, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria
4
Department of General and Clinical Pathology, Forensic Medicine, Deontology and Dermatovenerology, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(24), 13497; https://doi.org/10.3390/ijms252413497
Submission received: 13 November 2024 / Revised: 13 December 2024 / Accepted: 15 December 2024 / Published: 17 December 2024
(This article belongs to the Special Issue Oxidation in Human Health and Disease)
Browse Figures
Review Reports Versions Notes

Abstract

The present study aimed to investigate and compare oxidative stress biomarkers and antioxidant enzyme activity in the serum of women at risk of developing preeclampsia (PE) to prevent adverse pregnancy outcomes through early intervention. Changes in soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) levels were measured between 11 and 13 gestational weeks (gw.) before the onset of preeclampsia and its associated complications. This study evaluated the feasibility of the sFlt-1/PlGF biomarker ratio in predicting preeclampsia and adverse pregnancy outcomes, with the goal of preventive therapy with acetylsalicylic acid (150 mg daily), with acetylsalicylic acid (75 mg daily) and Clampsilin. For this purpose, the following were evaluated: (1) the levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS) as parameters of oxidative stress; (2) lipid oxidation; (3) antioxidant enzyme activity; and (4) cytokine production. Analysis of the results showed that pregnant women at risk of preeclampsia had significantly higher levels of ROS, lipid oxidation, and superoxide anion radical (•O2−) levels compared to normal pregnancies. In PE, depleted levels of nitric oxide (NO), impaired NO synthase system (NOS), and reduced antioxidant enzyme activity (p < 0.03) suggest that PE patients cannot compensate for oxidative stress (OS). In conclusion, oxidative stress in PE plays a key role, which arises from placental problems and affects both mother and baby. The groups with acetylsalicylic acid therapy (150 mg and 75 mg) were better affected compared to those on Clampsillin.
Keywords: pregnancy; preeclampsia; oxidative stress; NO; NOS pregnancy; preeclampsia; oxidative stress; NO; NOS

Share and Cite

MDPI and ACS Style

Kostadinova-Slavova, D.; Petkova-Parlapanska, K.; Koleva, I.; Angelova, M.; Sadi J. Al-Dahwi, R.; Georgieva, E.; Karamalakova, Y.; Nikolova, G. Preeclampsia Treatment Aspirin/Clampsilin: Oxidative Stress, sFlt-1/PIGF Soluble Tyrosine Kinase 1, and Placental Growth Factor Monitoring. Int. J. Mol. Sci. 2024, 25, 13497. https://doi.org/10.3390/ijms252413497

AMA Style

Kostadinova-Slavova D, Petkova-Parlapanska K, Koleva I, Angelova M, Sadi J. Al-Dahwi R, Georgieva E, Karamalakova Y, Nikolova G. Preeclampsia Treatment Aspirin/Clampsilin: Oxidative Stress, sFlt-1/PIGF Soluble Tyrosine Kinase 1, and Placental Growth Factor Monitoring. International Journal of Molecular Sciences. 2024; 25(24):13497. https://doi.org/10.3390/ijms252413497

Chicago/Turabian Style

Kostadinova-Slavova, Denitsa, Kamelia Petkova-Parlapanska, Irina Koleva, Mariya Angelova, Rafaah Sadi J. Al-Dahwi, Ekaterina Georgieva, Yanka Karamalakova, and Galina Nikolova. 2024. "Preeclampsia Treatment Aspirin/Clampsilin: Oxidative Stress, sFlt-1/PIGF Soluble Tyrosine Kinase 1, and Placental Growth Factor Monitoring" International Journal of Molecular Sciences 25, no. 24: 13497. https://doi.org/10.3390/ijms252413497

APA Style

Kostadinova-Slavova, D., Petkova-Parlapanska, K., Koleva, I., Angelova, M., Sadi J. Al-Dahwi, R., Georgieva, E., Karamalakova, Y., & Nikolova, G. (2024). Preeclampsia Treatment Aspirin/Clampsilin: Oxidative Stress, sFlt-1/PIGF Soluble Tyrosine Kinase 1, and Placental Growth Factor Monitoring. International Journal of Molecular Sciences, 25(24), 13497. https://doi.org/10.3390/ijms252413497

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop